ArticleResearch square2026
Timing of menstrual cups to prevent transition from optimal to not optimal vaginal microbiome community state type: Results from a 6.5-year prospective observational cohort.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: In a cluster randomized trial among Kenyan secondary schoolgirls, menstrual cups were associated with reduced bacterial vaginosis (BV) and increased optimal vaginal microbiome (VMB) community state type (CST-I) prevalence. The prevalence of CST-I decreased over time, suggesting non-optimal VMB is acquired. Using 6.5 years follow-up, we identified how menstrual cups and other factors drive CST transition. Methods: Participants were randomized to receive menstrual cups (intervention) or standard menstrual management (control). VMB and BV were measured 6-monthly and sexually transmitted infections (STIs; gonorrhea, chlamydia, trichomoniasis) and HSV-2 annually. Control participants received menstrual cups after the 30-month study visit. Continuous-time multi-state Markov modeling estimated the probability of CST transition, focusing on optimal CST-I ( Findings: Over 6.5 years, in 4,446 observations among 436 participants, CST-I prevalence decreased from 43.3% at baseline to 13.9%, and CST-IV increased from 18.1% at baseline to 44.6%. CST-I and CST-IV were more stable than CST-III. The probability of transition to CST-I from CST-III (16%) or CST-IV (9%) was infrequent. Participants initially randomized to menstrual cups had 54% reduced risk of transitioning from CST-I to CST-IV, adjusted for demographic and behavioral practices, BV, STIs, and HSV-2. Those who were poorer, older, sexually active, and HSV-2 seropositive were more likely to transition to less optimal CSTs. Interpretation: Over 6.5 years of observation, menstrual cups helped maintain CST-I VMB but did not demonstrate any therapeutic effect and should therefore be given to girls prior to sexual exposure to maximize the likelihood of achieving this benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.